Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer

Primo N Lara, David R Gandara, Ronald B. Natale

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)353-356
Number of pages4
JournalClinical Lung Cancer
Volume7
Issue number5
DOIs
StatePublished - Mar 2006

Fingerprint

irinotecan
Antineoplastic Combined Chemotherapy Protocols
Topoisomerase Inhibitors
Platinum Compounds
Camptothecin
Small Cell Carcinoma
Small Cell Lung Carcinoma
Etoposide
Cisplatin
Lung Neoplasms

Keywords

  • Combination therapy
  • Platinum compounds
  • Topoisomerase inhibitors

ASJC Scopus subject areas

  • Cancer Research
  • Pulmonary and Respiratory Medicine

Cite this

@article{4460a4389e494728b48a588b4f44f250,
title = "Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer",
keywords = "Combination therapy, Platinum compounds, Topoisomerase inhibitors",
author = "Lara, {Primo N} and Gandara, {David R} and Natale, {Ronald B.}",
year = "2006",
month = "3",
doi = "10.3816/CLC.2006.n.019",
language = "English (US)",
volume = "7",
pages = "353--356",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer

AU - Lara, Primo N

AU - Gandara, David R

AU - Natale, Ronald B.

PY - 2006/3

Y1 - 2006/3

KW - Combination therapy

KW - Platinum compounds

KW - Topoisomerase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=33745007372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745007372&partnerID=8YFLogxK

U2 - 10.3816/CLC.2006.n.019

DO - 10.3816/CLC.2006.n.019

M3 - Article

VL - 7

SP - 353

EP - 356

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 5

ER -